Zura Bio Limited Stock Price Prediction
| ZURA Stock | 1.28 0.20 18.52% |
Momentum 31
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.15) | EPS Estimate Current Year (0.59) | EPS Estimate Next Year (0.74) | Wall Street Target Price 15 | EPS Estimate Current Quarter (0.12) |
Using Zura Bio hype-based prediction, you can estimate the value of Zura Bio Limited from the perspective of Zura Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Zura Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Zura because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Zura Bio after-hype prediction price | USD 1.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Zura |
Zura Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Zura Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Zura Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Zura Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Zura Bio Estimiated After-Hype Price Volatility
In the context of predicting Zura Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Zura Bio's historical news coverage. Zura Bio's after-hype downside and upside margins for the prediction period are 0.06 and 7.50, respectively. We have considered Zura Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Zura Bio is risky at this time. Analysis and calculation of next after-hype price of Zura Bio Limited is based on 3 months time horizon.
Zura Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Zura Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zura Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Zura Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.90 | 6.22 | 0.00 | 0.38 | 6 Events / Month | 6 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.28 | 1.28 | 0.00 |
|
Zura Bio Hype Timeline
Zura Bio Limited is at this time traded for 1.28. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.38. Zura is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at -0.9%. %. The volatility of related hype on Zura Bio is about 1491.1%, with the expected price after the next announcement by competition of 1.66. About 32.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.46. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Zura Bio Limited had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Zura Bio Basic Forecasting Models to cross-verify your projections.Zura Bio Related Hype Analysis
Having access to credible news sources related to Zura Bio's direct competition is more important than ever and may enhance your ability to predict Zura Bio's future price movements. Getting to know how Zura Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Zura Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRK | Merck Company | 0.39 | 8 per month | 0.00 | (0) | 2.08 | (2.24) | 11.57 | |
| PFE | Pfizer Inc | 0.33 | 8 per month | 1.24 | 0.1 | 2.20 | (2.06) | 7.11 | |
| LLY | Eli Lilly and | (7.66) | 10 per month | 0.00 | 0.05 | 2.45 | (4.21) | 10.31 | |
| BMY | Bristol Myers Squibb | 0.64 | 9 per month | 1.88 | 0.07 | 3.18 | (2.80) | 7.43 | |
| JNJ | Johnson Johnson | 1.56 | 8 per month | 0.98 | 0.21 | 1.79 | (1.81) | 5.95 | |
| AMGN | Amgen Inc | 5.91 | 7 per month | 1.24 | 0.22 | 2.22 | (2.59) | 9.76 | |
| GILD | Gilead Sciences | 1.75 | 9 per month | 0.91 | 0.28 | 2.28 | (2.04) | 9.83 |
Zura Bio Additional Predictive Modules
Most predictive techniques to examine Zura price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zura using various technical indicators. When you analyze Zura charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Zura Bio Predictive Indicators
The successful prediction of Zura Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Zura Bio Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Zura Bio based on analysis of Zura Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Zura Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Zura Bio's related companies.
Story Coverage note for Zura Bio
The number of cover stories for Zura Bio depends on current market conditions and Zura Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zura Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zura Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Zura Bio Short Properties
Zura Bio's future price predictability will typically decrease when Zura Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zura Bio Limited often depends not only on the future outlook of the potential Zura Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zura Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.1 M | |
| Cash And Short Term Investments | 99.8 M |
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |